Skip to main content
. 2025 Sep 28;17(10):1314. doi: 10.3390/v17101314
irAEs Immune-related adverse events
CTL Cytotoxic T-lymphocyte
ICI Immune checkpoint inhibitor
PFS Progression-free survival
NSCLC Non-small cell lung cancer
TME tumor microenvironment
CRS cytokine release syndrome